This week, the overall grades of four Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Momenta Pharmaceuticals‘s (NASDAQ:MNTA) rating falls to a D (“sell”) this week, down from C (“hold”) the week prior. Momenta Pharmaceuticals is a biotechnology company. The stock also earns F’s in Portfolio Grader’s specific subcategories of Earnings Growth, Earnings Momentum, Earnings Revisions, and Sales Growth. For more information, get Portfolio Grader’s complete analysis of MNTA stock.
Vical Inc. (NASDAQ:VICL) gets weaker ratings this week as last week’s C drops to a D. Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The trailing PE Ratio for the stock is 339. For a full analysis of VICL stock, visit Portfolio Grader.
Slipping from a C to a D rating, Trius Therapeutics (NASDAQ:TSRX) takes a hit this week. Trius Therapeutics is a biopharmaceutical company. The stock also rates an F in Equity. Shares of the stock have been changing hands at an unusually rapid pace, twice the rate of the week prior. For more information, get Portfolio Grader’s complete analysis of TSRX stock.
This is a rough week for PROLOR Biotech (AMEX:PBTH). The company’s rating falls to D from the previous week’s C. PROLOR Biotech offers treatment by using naturally occurring amino acid sequence to slow the removal of therapeutic proteins from the body without increasing toxicity or altering the overall biological activity. The stock also gets an F in Equity. To get an in-depth look at PBTH, get Portfolio Grader’s complete analysis of PBTH stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
